In yet another study that genotyped 622 women with preeclampsia and 2027 controls (without preeclampsia) from the FINNPEC and National FINRISK cohorts, variants in complement receptor 3 (CR3) and complement receptor 4 (CR4) were identified (147). This evidence concerns the gene CRIPTO3 and preeclampsia.